Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Evome Medical Technologies Inc V.EVMT

Alternate Symbol(s):  LNDZF

Evome Medical Technologies Inc. is an international medical device company, which is focused on human performance and rehabilitative solutions. The Company’s products include Biodex Rehab product, Damar Plastics product, Mio-Guard product, Simbex services, and SDP product. Its Biodex Rehab products include Isokinetic Systems, Gait Trainer, Body-Weight Supported Training, Cycles and Ergometers, and Squat-Assist Trainer. Its Mio-Guard products include bags, cases and kits, braces, and supports, diagnostics and instruments, furniture, and equipment, padding and splinting, personal protection, sanitizers and disinfectants, and tapes and wraps. Its applications include fall risk screening and conditioning, patient-driven payment model (PDPM), wellness, sports medicine solutions, neurological involvement, safe patient handling and mobility, and senior living and rehabilitation. It offers concussion, fall screening and balance assessment and training programs.


TSXV:EVMT - Post by User

Post by screentasticon Dec 01, 2016 7:21am
94 Views
Post# 25538720

More Insider buying

More Insider buying
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Nov 30/16 Nov 30/16 Costine, David Clyde Direct Ownership Common Shares 10 - Acquisition in the public market 4,000 $0.370
Nov 30/16 Nov 30/16 Gerber, Jaime Ross Direct Ownership Common Shares 10 - Acquisition in the public market 14,700 $0.358
Nov 30/16 Nov 30/16 Brann, Edward Direct Ownership Common Shares 10 - Acquisition in the public market 100,000 $0.364
Nov 30/16 Nov 29/16 Costine, David Clyde Direct Ownership Common Shares 10 - Acquisition in the public market 4,000 $0.358
Nov 30/16 Nov 28/16 Costine, David Clyde Direct Ownership Common Shares 10 - Acquisition in the public market 4,000 $0.350
Bullboard Posts